Piper Sandler Cuts Myriad Genetics (NASDAQ:MYGN) Price Target to $9.00
Myriad Genetics (NASDAQ:MYGN – Free Report) had its target price decreased by Piper Sandler from $12.50 to $9.00 in a research report report published on Thursday,Benzinga reports. Piper Sandler currently has an overweight rating on the stock. MYGN has been the subject of several other reports. Raymond James reiterated an “outperform” rating and set a […]
Myriad Genetics (NASDAQ:MYGN – Free Report) had its target price decreased by Piper Sandler from $12.50 to $9.00 in a research report report published on Thursday,Benzinga reports. Piper Sandler currently has an overweight rating on the stock. MYGN has been the subject of several other reports. Raymond James reiterated an “outperform” rating and set a […]
